BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37291851)

  • 21. Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices.
    Tscharre M; Wittmann F; Kitzmantl D; Schlöglhofer T; Cichra P; Lee S; Eichelberger B; Wadowski PP; Laufer G; Wiedemann D; Panzer S; Zimpfer D; Gremmel T
    Thromb Haemost; 2023 Mar; 123(3):336-346. PubMed ID: 36402132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms.
    Akin M; Balkan C; Karapinar DY; Kavakli K
    Clin Appl Thromb Hemost; 2012 Jun; 18(3):316-9. PubMed ID: 21949039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.
    Northrop MS; Sidonio RF; Phillips SE; Smith AH; Daphne HC; Pietsch JB; Bridges BC
    Pediatr Crit Care Med; 2015 Jan; 16(1):66-74. PubMed ID: 25319630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.
    Hayakawa M; Takano K; Kayashima M; Kasahara K; Fukushima H; Matsumoto M
    J Atheroscler Thromb; 2021 Apr; 28(4):396-401. PubMed ID: 33116032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venoarterial extra corporeal membrane oxygenation and blood component usage in pediatric patients undergoing cardiac surgery: Single centre experience.
    Surti J; Jain I; Mishra A; Gajjar T; Solanki A; Patel J; Shah J; Shah S
    Ann Card Anaesth; 2021; 24(2):203-208. PubMed ID: 33884977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Venoarterial-Extracorporeal Membrane Oxygenation Without Routine Systemic Anticoagulation Decreases Adverse Events.
    Wood KL; Ayers B; Gosev I; Kumar N; Melvin AL; Barrus B; Prasad S
    Ann Thorac Surg; 2020 May; 109(5):1458-1466. PubMed ID: 31563493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of leukoreduced red blood cell transfusion on mortality of neonates undergoing extracorporeal membrane oxygenation.
    Jackson HT; Oyetunji TA; Thomas A; Oyetunji AO; Hamrick M; Nadler EP; Wong E; Qureshi FG
    J Surg Res; 2014 Nov; 192(1):6-11. PubMed ID: 25033708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circuit change during extracorporeal membrane oxygenation: single-center retrospective study of 48 changes.
    Genty T; Burguburu S; Imbert A; Roman C; Camille W; Thès J; Stéphan F
    Crit Care; 2023 Jun; 27(1):219. PubMed ID: 37269022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
    Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood use during extracorporeal membrane oxygenation.
    McCoy-Pardington D; Judd WJ; Knafl P; Abruzzo LV; Coombes KR; Butch SH; Oberman HA
    Transfusion; 1990 May; 30(4):307-9. PubMed ID: 2349629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of ABO blood group on mortality in major trauma.
    Hamsen U; Nohl A; Baumann A; Lefering R; Boutakmant L; Waydhas C; Dudda M; Schildhauer TA; Jäger M; Wegner A
    Orthop Rev (Pavia); 2019 Dec; 11(4):8214. PubMed ID: 31897279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
    Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
    Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms.
    Albánez S; Ogiwara K; Michels A; Hopman W; Grabell J; James P; Lillicrap D
    J Thromb Haemost; 2016 May; 14(5):953-63. PubMed ID: 26875505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bivalirudin Versus Unfractionated Heparin in Patients With Cardiogenic Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation.
    Uricchio MN; Ramanan R; Esper SA; Murray H; Kaczorowski DJ; D'Aloiso B; Gomez H; Sciortino C; Sanchez PG; Sappington PL; Rivosecchi RM
    ASAIO J; 2023 Jan; 69(1):107-113. PubMed ID: 35412480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No evidence for a direct effect of von Willebrand factor's ABH blood group antigens on von Willebrand factor clearance.
    Groeneveld DJ; van Bekkum T; Cheung KL; Dirven RJ; Castaman G; Reitsma PH; van Vlijmen B; Eikenboom J
    J Thromb Haemost; 2015 Apr; 13(4):592-600. PubMed ID: 25650553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of ABO blood group on von Willebrand factor tests in healthy Saudi blood donors.
    Alharbi A; Hassan SB; Al-Momen AK; Al-Saleh K; Nasr R; Kohgear H; Owaidah T
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):211-215. PubMed ID: 29369083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery.
    Kalbhenn J; Schlagenhauf A; Rosenfelder S; Schmutz A; Zieger B
    J Heart Lung Transplant; 2018 Aug; 37(8):985-991. PubMed ID: 29650295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of argatroban in patients receiving extracorporeal membrane oxygenation support: a case-control study].
    Zhang Z; Tang X; Wang R; Li X; Li Y; Tong Z; Sun B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Dec; 34(12):1305-1310. PubMed ID: 36567588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients.
    Refaai MA; Fialkow LB; Heal JM; Henrichs KF; Spinelli SL; Phipps RP; Masel E; Smith BH; Corsetti JP; Francis CW; Bankey PE; Blumberg N
    Vox Sang; 2011 Jul; 101(1):55-60. PubMed ID: 21414009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.
    O'Donnell J; Boulton FE; Manning RA; Laffan MA
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):335-41. PubMed ID: 11834538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.